The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
about
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@en
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@nl
type
label
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@en
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@nl
prefLabel
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@en
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@nl
P2093
P2860
P1476
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
@en
P2093
Francesca Carlomagno
Hong-Yu Li
Massimo Santoro
Valentina De Falco
P2860
P304
P356
10.1016/J.BEEM.2017.04.013
P577
2017-05-10T00:00:00Z